Q2 2023 · 13F-HR
Memorial Sloan Kettering Cancer Centerholdings as filed
Filed 2023-08-14 · accession 0000921895-23-001947
$31.7M
Reported value
5
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92189F106 | GDX | VANECK ETF TRUST | $22.2M | 70.2% | 738,500 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $4.7M | 14.8% | 602,272 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $2.3M | 7.30% | 544,196 | Common | SOLE |
| 984241109 | YMABUSD | Y-MABS THERAPEUTICS INC | $1.3M | 4.10% | 191,176 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $1.2M | 3.66% | 6,187 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.